______________________________________________________________________________________________ EKF
Diagnostics
Sciences in Indiana. This allowed our Texas facility to produce clinical chemistry products from the enzymes produced in Indiana.
“ We went on to acquire several more companies to expand our product portfolio, including DiaSpect, a producer of hemoglobin analyzers often used in blood banks to screen for signs of anemia,” he adds.“ After consolidating some of these business units, we created well-established divisions for both point-of-care diagnostics for both hematology and diabetes care.”
As the German part of the business has recently celebrated its 35th anniversary, we ask Gavin his reflections on reaching such an impressive milestone.“ We had lots of celebrations with as many people as we could, where we talked about the history of the business and what we’ ve achieved during the last 35 years,” he says.“ With the directors and former CEO present, the celebration events also provided a great opportunity for me to seamlessly and positively transition into the role of CEO.
“ There are also other milestones to be proud of, such as producing over 13,000 analyzers for the market last year and over 100 million tests sold. We’ ve grown from a German business focused on the European market to a global company with a network of over 120 distributors across more than 100 countries, supporting almost every kind of healthcare system across the globe. It’ s crucial to us that we provide products that make a difference to people’ s everyday lives and have a positive impact on their health. Our glycated hemoglobin offering, for instance, gives people with diabetes an understanding of where they are in terms of their glycemic control and the long-term impact it will have on their health moving forward.”
manufacturing-today. com 221